Chandelier
Senior Member (Voting Rights)
Healthy Control Population for PAIS-ME/CFS: Study to Evaluate Possible Biomarkers and Methods for Examination of PAIS-ME/CFS Diagnostics in Healthy Volunteers (HelP)
ClinicalTrials.gov ID NCT06653712
Sponsor Technical University of Munich
Last Update Posted 2024-10-22
Using the data from the HelP study, the underlying processes of the diseases ME/CFS and PAIS are to be researched and elucidated.
The comparison of affected patients with healthy controls is intended to identify disease-specific patterns that could be related to the development or progression of the disease.
The aim is to find a suitable biomarker for diagnostics and to develop therapeutic approaches.
Detailed Description
The underlying pathomechanisms of the diseases PAIS and ME/CFS are to be investigated and elucidated in more detail.
The aim is to establish a cohort of healthy controls at our MRI Chronic Fatigue Center (MCFC).
Within this cohort, the measurement instruments used so far in ME/CFS diagnostics will be validated.
In addition, data material from this pool should be used for the statistical evaluations of various case-control studies of our center and our cooperation partners in order to find and develop a suitable biomarker for diagnostics and therapeutic approaches for PAIS and ME/CFS.
Official Title
Healthy Control Population für PAIS-ME/CFS: Studie Zur Evaluation möglicher Biomarker Und Untersuchungsmethoden für Die PAIS-ME/CFS-Diagnostik Bei Gesunden Probanden
Study Start (Estimated)
2024-10
Primary Completion (Estimated)
2029-12
Study Completion (Estimated)
2029-12
Enrollment (Estimated)
200
Study Type
Observational
Study Contact
Name: Prof. Dr. med. Uta Behrends
Phone Number: +49 89 3068 2793
Email: uta.behrends@mri.tum.de
ClinicalTrials.gov ID NCT06653712
Sponsor Technical University of Munich
Last Update Posted 2024-10-22
Study Overview
Brief SummaryUsing the data from the HelP study, the underlying processes of the diseases ME/CFS and PAIS are to be researched and elucidated.
The comparison of affected patients with healthy controls is intended to identify disease-specific patterns that could be related to the development or progression of the disease.
The aim is to find a suitable biomarker for diagnostics and to develop therapeutic approaches.
Detailed Description
The underlying pathomechanisms of the diseases PAIS and ME/CFS are to be investigated and elucidated in more detail.
The aim is to establish a cohort of healthy controls at our MRI Chronic Fatigue Center (MCFC).
Within this cohort, the measurement instruments used so far in ME/CFS diagnostics will be validated.
In addition, data material from this pool should be used for the statistical evaluations of various case-control studies of our center and our cooperation partners in order to find and develop a suitable biomarker for diagnostics and therapeutic approaches for PAIS and ME/CFS.
Official Title
Healthy Control Population für PAIS-ME/CFS: Studie Zur Evaluation möglicher Biomarker Und Untersuchungsmethoden für Die PAIS-ME/CFS-Diagnostik Bei Gesunden Probanden
Study Start (Estimated)
2024-10
Primary Completion (Estimated)
2029-12
Study Completion (Estimated)
2029-12
Enrollment (Estimated)
200
Study Type
Observational
Study Contact
Name: Prof. Dr. med. Uta Behrends
Phone Number: +49 89 3068 2793
Email: uta.behrends@mri.tum.de